Charles Brenner

ORCID: 0000-0002-4955-3226
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sirtuins and Resveratrol in Medicine
  • Calcium signaling and nucleotide metabolism
  • Psychotherapy Techniques and Applications
  • PARP inhibition in cancer therapy
  • Genetics and Neurodevelopmental Disorders
  • Adipose Tissue and Metabolism
  • Biochemical and Molecular Research
  • Forensic and Genetic Research
  • Autophagy in Disease and Therapy
  • Peptidase Inhibition and Analysis
  • Epigenetics and DNA Methylation
  • Ubiquitin and proteasome pathways
  • Molecular Biology Techniques and Applications
  • RNA modifications and cancer
  • Mitochondrial Function and Pathology
  • Fungal and yeast genetics research
  • Academic and Historical Perspectives in Psychology
  • Adenosine and Purinergic Signaling
  • Genetics, Aging, and Longevity in Model Organisms
  • Tryptophan and brain disorders
  • Genetics, Bioinformatics, and Biomedical Research
  • Psychoanalysis and Psychopathology Research
  • Epilepsy research and treatment
  • Cancer-related gene regulation
  • Cytomegalovirus and herpesvirus research

University of Iowa
2014-2024

Beckman Research Institute
2022-2024

City of Hope
2022-2024

City Of Hope National Medical Center
2020-2024

Parsons (United States)
2023

The Wallace H. Coulter Department of Biomedical Engineering
2023

Georgia Institute of Technology
2022-2023

University of California, Berkeley
2001-2021

Carver Bible College
2010-2014

The University of Texas Health Science Center at San Antonio
1998-2013

Morpholino phosphorodiamidate antisense oligonucleotides (MOs) and short interfering RNAs (siRNAs) are commonly used platforms to study gene function by sequence-specific knockdown. Both technologies, however, can elicit undesirable off-target effects. We have several model genes these effects in detail the zebrafish, Danio rerio. Using zebrafish embryo as a template, correct mistargeting readily discernible through direct comparison of MO-injected animals with well-studied mutants. show...

10.1371/journal.pgen.0030078 article EN cc-by PLoS Genetics 2007-05-23

Abstract Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood metabolism humans. We report that human can rise much 2.7-fold with a single oral dose pilot study one individual, elevates mouse hepatic distinct superior pharmacokinetics to those nicotinic acid nicotinamide. further show doses 100, 300 1,000 mg produce increases metabolome first clinical trial also adenine dinucleotide (NAAD), which was not...

10.1038/ncomms12948 article EN cc-by Nature Communications 2016-10-10

Nicotinamide adenine dinucleotide (NAD+) is modulated by conditions of metabolic stress and has been reported to decline with aging in preclinical models, but human data are sparse. riboside (NR) supplementation ameliorates dysfunction rodents. We aimed establish whether oral NR aged participants can increase the skeletal muscle NAD+ metabolome if it alter mitochondrial bioenergetics. supplemented 12 men 1 g per day for 21 days a placebo-controlled, randomized, double-blind, crossover trial....

10.1016/j.celrep.2019.07.043 article EN cc-by Cell Reports 2019-08-01

Abstract NAD + is a vital redox cofactor and substrate required for activity of various enzyme families, including sirtuins poly(ADP-ribose) polymerases. Supplementation with precursors, such as nicotinamide mononucleotide (NMN) or riboside (NR), protects against metabolic disease, neurodegenerative disorders age-related physiological decline in mammals. Here we show that kinase 1 (NRK1) necessary rate-limiting the use exogenous NR NMN synthesis. Using genetic gain- loss-of-function models,...

10.1038/ncomms13103 article EN cc-by Nature Communications 2016-10-11

Background: Myocardial metabolic impairment is a major feature in chronic heart failure. As the coenzyme fuel oxidation and oxidative phosphorylation substrate for enzymes signaling energy stress response, nicotinamide adenine dinucleotide (NAD + ) emerging as target number of diseases including Little known on mechanisms regulating homeostasis NAD failing heart. Methods: To explore possible alterations heart, we quantified expression biosynthetic human mouse model dilated cardiomyopathy...

10.1161/circulationaha.116.026099 article EN Circulation 2017-12-07

Abstract Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance sensory neuropathy. The same given low doses of streptozotocin are a model type 2 diabetes (T2D), developing hyperglycemia, severe diabetic peripheral neuropathy involving motor neurons. Because suggestions that increased NAD + metabolism might address glycemic control be neuroprotective, we treated T2D with nicotinamide riboside (NR) added to HFD. NR improved glucose tolerance,...

10.1038/srep26933 article EN cc-by Scientific Reports 2016-05-27

Poly(ADP-ribose) polymerase (PARP) superfamily members covalently link either a single ADP-ribose (ADPR) or chain of ADPR units to proteins using NAD as the source ADPR. Although well-known poly(ADP-ribosylating) (PARylating) PARPs primarily function in DNA damage response, many noncanonical mono(ADP-ribosylating) (MARylating) are associated with cellular antiviral responses. We recently demonstrated robust up-regulation several following infection murine hepatitis virus (MHV), model...

10.1074/jbc.ra120.015138 article EN cc-by Journal of Biological Chemistry 2020-10-14

Nicotinamide riboside (NR) is a newly discovered nicotinamide adenine dinucleotide (NAD+) precursor vitamin. A crystal form of NR chloride termed NIAGEN generally recognized as safe (GRAS) for use in foods and the subject two New Dietary Ingredient Notifications dietary supplements. To evaluate kinetics dose-dependency oral availability safety overweight, but otherwise healthy men women, an 8-week randomized, double-blind, placebo-controlled clinical trial was conducted. Consumption 100, 300...

10.1038/s41598-019-46120-z article EN cc-by Scientific Reports 2019-07-05

Nicotinamide adenine dinucleotide (NAD+) precursor nicotinamide riboside (NR) has emerged as a promising compound to improve obesity-associated mitochondrial dysfunction and metabolic syndrome in mice. However, most short-term clinical trials conducted so far have not reported positive outcomes. Therefore, we aimed determine whether long-term NR supplementation boosts biogenesis health humans. Twenty body mass index (BMI)-discordant monozygotic twin pairs were supplemented with an escalating...

10.1126/sciadv.add5163 article EN cc-by-nc Science Advances 2023-01-13
Coming Soon ...